Table 5.
Median biochemical and haematological (range) values with study feed replacing one ingredient and after 18 months when all modular ingredients replaced.
| Pre-study (week − 8) median (range) | Phase 1 (week 26) median (range) | Statistical significance pre-study to phase 1 n = 13 | Phase 2 (week 79) median (range) | Statistical significance pre-study to phase 2 n = 13 | Reference range | |
|---|---|---|---|---|---|---|
| Plasma zinc μmol/L | 10.9 (8.9–14.6) | 10.7 (7–15.3) | p = 0.98 | 12.5 (7–16.5) | p = 0.03 | 10–18 |
| Plasma selenium μmol/L | 0.96 (0.6–1.2) | 1.11 (0.8–1.4) | p = 0.002 | 1.2 (0.9–1.5) | p = 0.01 | 0.8–8.2 |
| Ferritin μg/L | 34 (5.3–121) | 39.2 (7.8–167) | p = 0.12 | 38.5 (9–93) | p = 0.8 | 32–233 |
| Vitamin B12 ng/L | 957 (208–1049) | 977 (166–2121) | p = 0.95 | 760 (114–1500) | p = 0.2 | 259–823 |
| Haemoglobin g/dL | 122.9 (103–139) | 123.8 (114–136) | p = 0.84 | 130 (109–161) | p = 0.05 | 112–130 |
| MCV g/L | 75 (65–83) | 76 (68–84) | p = 0.22 | 85 (73–94) | p = 0.005 | 75–90 |
| C reactive protein mg/L | 2.6 (1 − 13) | 2.9 (1–19) | p = 0.9 | 2.3 (1 − 12) | p = 0.9 | < 10 |
| Urine sodium mmol/L | – | 80 (22–300) | 40–220 | |||
| Urine potassium mmol/L | – | 41 (13–236) | 10–60 |